Stifel raises Disc Medicine stock target to $94, maintains Buy

On Friday, Stifel analysts increased their price target for Disc Medicine (NASDAQ:IRON) shares to $94.00, up from the previous $90.00. Currently trading at $57.07 with a market capitalization of $1.7 ...
Business Insider

Disc Medicine price target raised to $73 from $70 at Scotiabank

Scotiabank analyst Greg Harrison raised the firm’s price target on Disc Medicine (IRON) to $73 from $70 and keeps an Outperform rating on the shares. The company has significantly decreased the ...
Nasdaq

Twin Disc (TWIN) Price Target Increased by 37.14% to 24.48

The average one-year price target for Twin Disc (NasdaqGS:TWIN) has been revised to $24.48 / share. This is an increase of 37.14% from the prior estimate of $17.85 dated November 7, 2025. The price ...
Business Insider

Disc Medicine price target raised to $70 from $62 at Scotiabank

Scotiabank raised the firm’s price target on Disc Medicine (IRON) to $70 from $62 and keeps an Outperform rating on the shares. The firm views the company’s end-of-phase 2 FDA meeting update as a ...